Put Options

13 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$101.21 - $166.61 $16.3 Million - $26.8 Million
-160,700 Reduced 49.84%
161,700 $19.2 Million
Q1 2024

May 15, 2024

BUY
$85.37 - $115.44 $3.05 Million - $4.12 Million
35,700 Added 12.45%
322,400 $34.4 Million
Q4 2023

Feb 14, 2024

SELL
$69.51 - $104.43 $11.8 Million - $17.7 Million
-169,500 Reduced 37.15%
286,700 $28.5 Million
Q2 2023

Aug 14, 2023

BUY
$118.5 - $160.53 $13.5 Million - $18.3 Million
113,700 Added 33.2%
456,200 $55.4 Million
Q1 2023

May 15, 2023

BUY
$135.66 - $197.02 $18.9 Million - $27.4 Million
139,100 Added 68.39%
342,500 $52.6 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $12.2 Million - $21.6 Million
-102,800 Reduced 33.57%
203,400 $36.5 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $1.85 Million - $3.05 Million
15,700 Added 5.4%
306,200 $36.2 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $15 Million - $22.6 Million
128,100 Added 78.88%
290,500 $41.5 Million
Q1 2022

May 16, 2022

SELL
$126.46 - $235.05 $7.97 Million - $14.8 Million
-63,000 Reduced 27.95%
162,400 $28 Million
Q4 2021

Feb 14, 2022

SELL
$225.82 - $368.51 $5.67 Million - $9.25 Million
-25,100 Reduced 10.02%
225,400 $57.2 Million
Q3 2021

Nov 15, 2021

BUY
$221.9 - $484.47 $155,330 - $339,129
700 Added 0.28%
250,500 $96.4 Million
Q2 2021

Aug 16, 2021

BUY
$129.91 - $234.98 $5.63 Million - $10.2 Million
43,300 Added 20.97%
249,800 $58.7 Million
Q1 2021

May 17, 2021

BUY
$109.18 - $185.98 $22.5 Million - $38.4 Million
206,500 New
206,500 $27 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.